Octapharma Accepting Applications for Research Grants on Immunotherapy, Coagulation Disorders and Critical Care
... or pre-clinical research focused on human
protein therapies in coagulation disorders, ... patients with the safest, highest quality human
protein therapies available is stronger than ever," said ... production and sale of high quality human
protein therapies, including immune globulin ...
Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease
... activity of the toxic oligomeric form of Abeta
protein that interferes with normal learning and memory. ... that the memory deficits caused by the oligomeric
protein are among the earliest changes seen in ... indicate that blocking the effects of this
protein may halt or reverse Alzheimer's disease. ...
Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class
... aTyr Pharma's new class of naturally occurring
protein agents. The aminoacyl tRNA synthetases are universal and essential components of
protein synthesis machinery found in all organisms, but ... with cell signaling activities distinct from the
protein synthesis activities. In this recently ...
Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
... with novel characteristics for pharmaceutical
protein production purposes using Sangamo's proprietary zinc finger DNA-binding
protein nuclease (ZFN) technology. Genentech scientists ... being used by major players in pharmaceutical
protein production to streamline the process of cell line ...
Alfacell Provides Shareholder Update
... gene1 and the multidrug resistance associated
protein gene make proteins which act like pumps to keep ... if Onconase is able to down regulate the
protein produced by the MDR1 gene. There is ample ... ribonuclease (RNase) technology. A natural
protein isolated from the leopard frog, ONCONASE has been ...
Isis Highlights New Data on Antisense Drugs to Treat Type 2 Diabetes and Obesity at ADA Scientific Sessions
... that antisense reduction of retinal binding
protein 4 (RBP4) caused significant improvements in ... Inhibition of cAMP Response Element Binding
protein (CREB)
Expression Lowers Plasma Glucose and ... of Carbohydrate Response Element Binding
protein (ChREBP) in
Liver Protects Against Fructose ...
Scientists at The Karmanos Cancer Institute in Detroit Identify Potential New Target for Breast Cancer Therapy
... human breast carcinomas and discovered that the
protein EZH-2 was expressed in 74 percent of those cases. ... "We wanted to see how much expression of the
protein was present. We were surprised that 74 percent of ... The discovery of the high rate of EZH-2
protein expression in breast cancer cases opens up a new ...
AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria
... PBGD gene result in insufficient activity of a
protein necessary for
the synthesis of heme. This leads ... AMT-021, results in normalization of the PBGD
protein in an animal
model of AIP. In this model, the ... to provide long-term normalization of the
PBGD
protein in order to prevent acute porphyric attacks and ...
Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
... comprising administering receptor-associated
protein ("RAP") fragments conjugated to active agents ." ... is Raptor's proprietary receptor-associated
protein ("RAP")-based technology program designed to ... has also been conjugated to a variety of
protein drugs, including enzymes and growth factors, ...
Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting
... tomatoes on vasodilatation and C-reactive
protein in overweight and obese men and women, presented ... lower serum C-reactive protein. C-reactive
protein is a recognized biomarker of inflammation.
... through dietary strategies) and C-reactive
protein on overweight and obese men and women. Within the ...
Cylene to Present Advances in its Oral Inhibitor of CK2 at AACR Annual Meeting
... of CX-4945, a first-in-class oral inhibitor of
protein kinase CK2. CK2 overexpression is well ... orally bioavailable small molecule inhibitor of
protein kinase CK2: Phase I initiated - Experimental ... inhibitors of cancer-linked serine/threonine
protein kinases, as well as innovative nucleolus ...
Osprey Pharmaceuticals U.S.A., Inc. Initiates Phase Ib Clinical Trial in IgA Nephropathy
... is developing novel chemokine-enzyme fusion
protein therapeutics, known as Leukocyte Population ... U.S.A. is focused on the development of
protein therapeutics for the treatment of inflammatory ... a pipeline of proprietary LPMs, novel fusion
protein therapeutics designed to selectively and ...
Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
... oral cancer treatment to directly target mTOR, a
protein inside the cell that controls tumor cell division ... globally(1).
Afinitor inhibits mTOR, a
protein in the cancer cell that controls tumor cell ... cells, Afinitor continuously targets mTOR, a
protein that acts as a central regulator of tumor cell ...
Key Protein May Lead to Faster Acting Anti-Depression Drugs
... in the Journal of Neuroscience that the brain
protein called p11 could lead pharmaceutical companies to ... of 5-HT4 Receptor Stimulation , solidifies the
protein p11 as a key determinant of vulnerability to ... Physiology, helped establish p11 as an important
protein that regulates signaling in the brain by the ...
Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
... physical interaction between the beta amyloid
protein and melatonin, a close structural homolog of ... species produced in the brain by beta-amyloid
protein bound primarily to copper ions," commented ... with other compounds, referred to as metal
protein attenuating compounds, which have begun to show ...
PTC Therapeutics Completes Enrollment of Pivotal Trial in Muscular Dystrophy
... formation of functioning dystrophin, the missing
protein in patients with nmDMD/BMD."
This is the ... to terminate translation before a full-length
protein is generated. This causes the
protein to be truncated and non-functioning. Ataluren is ...
Medgenics Announces Positive Data From Phase I/II Clinical Trial of EPODURE Treatment of Anemia in Chronic Kidney Disease
... safety and efficacy for the sustained
protein therapy of anemia in patients with chronic kidney ... delivering the low dose of 18-25 IU/kg/day of the
protein erythropoietin (EPO), was sufficient to sustain ... first practical treatment to provide sustained
protein therapy and serve as an alternative to expensive, ...
Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
... protein, CTP extends the time that the
protein is active in the body. The potential utility of ... and the effectiveness of Modigene's long-acting
protein programs, that are made pursuant to the safe ... commercial products based upon its long-acting
protein technology, including any long-acting versions of ...
Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2
... a Phase I clinical trial of its oral CK2
protein kinase inhibitor, CX-4945, in patients with ... potent inhibition of CK2, a constitutively active
protein kinase that is overexpressed in a wide range of ... Affairs.
About CX-4945, an oral CK2
protein kinase inhibitor
CX-4945 is a first-in-class ...
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults
... through further oxidation, the resulting modified
protein is described as an Advanced Glycation End Product ... heart, kidney and skin among others. Collagen (a
protein normally found in connective and structural tissue) is an example of a
protein that can be converted into an A.G.E. As a ...
Vical Pandemic Influenza Vaccines Achieve T-Cell Responses and Cross-Clade Reactivity in Humans
... of DNA) encoding the hemagglutinin (HA) surface
protein from the H5N1 influenza virus strain, ... to elicit antibody responses against the H5
protein but could elicit T-cell responses against H5 as ... proteins: nucleoprotein (NP) and ion channel
protein (M2). The trivalent vaccine was designed to ...
SARS Vaccine Achieves Neutralizing Responses in First U.S. Human Trial
... diseases or cancer, in
which the expressed
protein is an immunogen; cancer immunotherapeutics, in
which the expressed
protein is an immune system stimulant; and cardiovascular
therapies, in which the expressed
protein is an angiogenic growth factor. The
company is ...
Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey
... for cancer, in which the
expressed
protein is an immune system stimulant; DNA vaccines for infectious
diseases, in which the expressed
protein is an immunogen; and cardiovascular
therapies, in which the expressed
protein is an angiogenic growth factor. The
company is ...
Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
... diseases or cancer, in which the expressed
protein is an immunogen; cancer immunotherapeutics, in which the expressed
protein is an immune system stimulant; and cardiovascular therapies, in which the expressed
protein is an angiogenic growth factor. The company is ...
New Insight Into the Controls on a Go-To Enzyme
... control, which is the job of another
protein called calpastatin. A central question has been ... In this widely used method of determining
protein structure, researchers first crystallize a
protein to be studied. Then, they direct X-rays through ...
Vical Completes Enrollment and Reports Positive Interim Data in CMV Vaccine Phase 2 Trial
... or cancer, in which the expressed
protein is an immunogen; cancer
immunotherapeutics, in which the expressed
protein is an immune system
stimulant; and cardiovascular therapies, in which the expressed
protein is
an angiogenic growth factor. The company is ...
U.S. Navy and U.S. Army to Develop Dengue DNA Vaccine Formulated With Vical's Vaxfectin(R) Adjuvant
... or cancer, in which the expressed
protein is an immunogen; cancer
immunotherapeutics, in which the expressed
protein is an immune system
stimulant; and cardiovascular therapies, in which the expressed
protein is
an angiogenic growth factor. The company is ...
Raptor Pharmaceuticals Provides Update on Targeting Platforms
... Enters Collaboration on Receptor Associated
protein (RAP)
Supports NeuroTrans(TM) Platform with ... derived from the human receptor-associated
protein ("RAP") and
related proteins. The Company signed ... derived from the human receptor-associated
protein ("RAP") and
related proteins to that are designed ...
PTC Announces Data Showing That PTC124 Causes Statistically Significant Improvements in Chloride Channel Function in Cystic Fibrosis Patients
... conductance regulator (CFTR)
protein and a statistically
significant decrease in the ... and in apical expression of CFTR
protein in nasal epithelium.
The study enrolled 30 ... goal of demonstrating that
increasing functional
protein levels in patients with nonsense mutation
genetic ...
Insmed Initiates Clinical Study for Follow-on Biologic Version of Neulasta(R)
... of our FOB portfolio, utilizing our unique
protein drug
development capabilities and technical ... glycol is
attached to the protein. The pegylated
protein has a prolonged biological
activity after it is ... Inc. is a biopharmaceutical company with unique
protein process
development and manufacturing experience ...
Protein Shown to Play a Key Role in Normal Development of Nervous System
... PHILADELPHIA, Oct. 8 /PRNewswire-USNewswire/ -- A
protein that enables
nerve cells to communicate with each ... developing nervous system. Research into how that
protein helps precise
connections to form among nerve ... first study, published Oct. 1, showed that the
protein GluR1, which
is a receptor for the ...
Vical Expands Applications of Vaxfectin(R) Adjuvant for Infectious Disease and Cancer Vaccines; 80% to 100% of High-Dose Responders in H5N1 Clinical Trials Still Responding at 6 Months
... containing a
peptide from Tyrosinase-Related
protein 2 (TRP-2), an antigen commonly
expressed by ... or cancerous
cells.
Vaxfectin(R)-formulated
protein Vaccines
Vical has previously reported that ... or cancer, in which the expressed
protein is an immunogen; cancer
immunotherapeutics, in ...
Burcon announces GRAS status for Puratein(R) & Supertein(TM)
... that its Puratein(R) and
Supertein(TM) canola
protein isolates are GRAS (Generally Recognized As
Safe) ... dollar global protein
ingredient market.
protein ingredients are valued for both their
nutritional ... in foods and
beverages.
Puratein(R) is a canola
protein isolate with functional properties that
include ...
Data from In Vivo Disease Models on Taligen Therapeutics' Pipeline Candidates to be Presented at the XXII International Complement Workshop
... Animal Data on Previously
Disclosed Fusion
protein TT30 and New Molecules TT32 and mAb171
... Five
studies testing the company's fusion
protein TT30 and two new compounds, a
fusion
protein TT32 and a monoclonal antibody mAb171, in animal ...
InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
... formulation excipient. Cellastim is a recombinant
protein and has been shown to improve mammalian cell ... to chicken lysozyme and provides higher
protein yield compared with mechanical cell lysis. ... in bacterial fermentation to improve recombinant
protein yields.(see http://www.Lysobac.com )
For ...
The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC
... Summary:
protein Tomography(TM) has yet Again Provided Structural ... the molecular mechanism
of the Synaptic Vesicle
protein 2A (SV2A) in mouse brain tissue. SV2A is
the ... to either
side of the membrane. Prior to this
protein Tomography(TM) study, great
efforts were made to ...
Karolinska Institutet to Test Vical's Vaxfectin(R) Adjuvant With Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
... or cancer, in which the expressed
protein is an immunogen; cancer
immunotherapeutics, in which the expressed
protein is an immune system
stimulant; and cardiovascular therapies, in which the expressed
protein is
an angiogenic growth factor. The company is ...
Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
... or cancer, in which the expressed
protein is an immunogen; cancer
immunotherapeutics, in which the expressed
protein is an immune system
stimulant; and cardiovascular therapies, in which the expressed
protein is
an angiogenic growth factor. The company is ...
ProteoTech's Exebryl-1(R) Enters Human Clinical Trials for the Treatment of Alzheimer's Disease
... small molecule drug targeting
toxic beta-amyloid
protein accumulation for the treatment of ... these animals. Toxic and insoluble beta-amyloid
protein accumulation is
believed to be an important part ... that is believed to
prevent beta-amyloid
protein formation, deposition, and accumulation at ...
Phase II Data on Lilly's Antibody Show It Affects Amyloid Beta, a Protein Believed To Be Associated with Alzheimer's Disease
... plaque and other forms of the
amyloid beta
protein in the brain may result in slowing of the ... plaques or other types of the amyloid beta
protein are
thought ultimately to disrupt normal nerve ... in the
two major forms of the amyloid beta
protein seen in blood and cerebrospinal
fluid, an ...